Liu, S., Lan, B., Wang, Y., Yang, T., Li, L., Ge, H., . . . Ma, F. (2024, November). Pyrotinib and trastuzumab combination treatment synergistically overcomes HER2 dependency in HER2-positive breast cancer: Insights from the PHILA trialResearch in context. EBioMedicine.
Chicago Style (17th ed.) CitationLiu, Shuning, et al. "Pyrotinib and Trastuzumab Combination Treatment Synergistically Overcomes HER2 Dependency in HER2-positive Breast Cancer: Insights from the PHILA TrialResearch in Context." EBioMedicine Nov. 2024.
MLA (9th ed.) CitationLiu, Shuning, et al. "Pyrotinib and Trastuzumab Combination Treatment Synergistically Overcomes HER2 Dependency in HER2-positive Breast Cancer: Insights from the PHILA TrialResearch in Context." EBioMedicine, Nov. 2024.
Warning: These citations may not always be 100% accurate.